Completed NA INTERVENTIONAL 2-arm NCT06033079

Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2) (ICE-CAP2)

Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP1): Prognostic Decision Support

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Updated 4 times since 2023 Last updated: Nov 13, 2023 Started: Nov 20, 2020 Primary completion: Nov 30, 2022 Completion: Nov 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Pneumonia Childhood, this trial is completed. The trial is conducted by National Institute of Allergy and Infectious Diseases (NIAID) and has accumulated 4 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2024 — Jul 2024 [monthly]

Completed NA
Oct 2023 — Jan 2024 [monthly]

Completed NA

First recorded

Nov 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Allergy and Infectious Diseases (NIAID)
University of Pittsburgh Medical Center
Vanderbilt University Medical Center

Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nashville, United States